Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Solana Company (HSDT)
USD1.73
-0.02 (-1.14%)
US NASDAQ Healthcare Medical - Devices
Address
642 Newtown Yardley Road 18940
Newtown, PA, US
Newtown, PA, US
CEO
Dane Carl Andreeff
Website
solana.com
IPO
2014-06-27
CIK 1610853 ISIN US42328V8761
Also trades on
NASDAQ Capital Market · HSDT (USD)
Toronto Stock Exchange · HSM.TO (CAD)
Description
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.73
-0.02 (-1.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
343.2K
Beta
1.03
Float Shares
24.44M
Free Float %
60.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.77% | +2.22% | +8.49% | +13.86% | -46.51% | -20.42% | -99.04% | -99.96% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
1.73
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
17.18
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+1,057.1% ★ Q1'26: +7,289.8% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+57.3% ★ Q1'26: +8.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-675.8% Q1'26: -133.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-669.0% Q1'26: -48.3% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-13.7% Q1'26: -3.6% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+713.6% Q1'26: +2,731.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 3.54M (-100.0%)
|
1.50M
est: 1.50M (-0.3%)
|
661.0K
est: 640.0K (+3.3%)
|
522.0K
est: 360.0K (+45.0%)
|
787.0K
est: 765.7K (+2.8%)
|
644.0K
est: 594.0K (+8.4%)
|
520.0K
est: 468.0K (+11.1%)
|
6.02M
est: 374.0K (+1,508.8%)
|
12.65M
11.82M – 13.48M
+3,282.4% YoY
|
13.15M
12.29M – 14.01M
+4.0% YoY
|
18.00M
16.82M – 19.18M
+36.9% YoY
|
| EBITDA |
-28.01M
est: -3.54M (-691.2%)
|
-9.59M
est: -1.50M (-539.3%)
|
-13.65M
est: -640.0K (-2,032.5%)
|
-17.82M
est: -360.0K (-4,850.0%)
|
-14.50M
est: -765.7K (-1,794.3%)
|
-12.11M
est: -594.0K (-1,938.2%)
|
-13.80M
est: -468.0K (-2,849.4%)
|
-40.26M
est: -374.0K (-10,663.4%)
|
-12.65M
-13.48M – -11.82M
-3,282.4% YoY
|
-13.15M
-14.01M – -12.29M
-4.0% YoY
|
-18.00M
-19.18M – -16.82M
-36.9% YoY
|
| EBIT |
-28.02M
est: -3.54M (-691.6%)
|
-9.78M
est: -1.50M (-552.1%)
|
-14.13M
est: -640.0K (-2,107.8%)
|
-18.13M
est: -360.0K (-4,936.7%)
|
-14.76M
est: -765.7K (-1,827.6%)
|
-12.27M
est: -594.0K (-1,965.5%)
|
-13.86M
est: -468.0K (-2,862.2%)
|
-40.26M
est: -374.0K (-10,663.4%)
|
-12.65M
-13.48M – -11.82M
-3,282.4% YoY
|
-13.15M
-14.01M – -12.29M
-4.0% YoY
|
-18.00M
-19.18M – -16.82M
-36.9% YoY
|
| Net Income |
-28.02M
est: -3.73T (+100.0%)
|
-9.78M
est: -1.32T (+100.0%)
|
-14.13M
est: -1.42T (+100.0%)
|
-18.13M
est: -751.96B (+100.0%)
|
-14.07M
est: -198.15B (+100.0%)
|
-8.85M
est: -168.00M (+94.7%)
|
-11.74M
est: -93.26B (+100.0%)
|
-40.89M
est: -5.59B (+99.3%)
|
-11.91M
-12.92M – -10.89M
+99.8% YoY
|
-5.29M
-5.74M – -4.84M
+55.6% YoY
|
-8.38M
-9.09M – -7.66M
-58.3% YoY
|
| SGA |
8.45M
est: 60.13M (-85.9%)
|
16.52M
est: 25.48M (-35.2%)
|
9.40M
est: 10.87M (-13.5%)
|
12.18M
est: 6.11M (+99.1%)
|
10.64M
est: 13.00M (-18.2%)
|
9.27M
est: 8.86M (+4.7%)
|
10.12M
est: 6.98M (+45.0%)
|
23.13M
est: 5.58M (+314.8%)
|
188.59M
176.20M – 200.99M
+3,282.4% YoY
|
196.05M
183.16M – 208.93M
+4.0% YoY
|
268.35M
250.72M – 285.99M
+36.9% YoY
|
| EPS |
-1,316.05
est: -1,378,125.00 (+99.9%)
|
-324.78
est: -485,625.00 (+99.9%)
|
-294.93
est: -525,000.00 (+99.9%)
|
-184.51
est: -277,500.00 (+99.9%)
|
-26.06
est: -73,125.00 (+100.0%)
|
-7.28
est: -7.62 (+4.5%)
|
-4.33
est: -4,230.00 (+99.9%)
|
-1.85
est: -253.50 (+99.3%)
|
-0.54
-0.59 – -0.49
+99.8% YoY
|
-0.24
-0.26 – -0.22
+55.6% YoY
|
-0.38
-0.41 – -0.35
-58.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-14.94M
OE per share TTM
-4.21
Owner's Yield
-8.89%
Maintenance CapEx ratio
0.45%
Maint CapEx / Avg PPE
28.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
6
Total invested
8.36M
Insider transactions (90d)
2
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Advanced NeuroRehabilitation, LLC | 16.04M | 22.20% | — | 16.04M | — | 8.82M | OO | Wisconsin | 2016-02-16 | ↗ |
| 2 | Kurt Kaczmarek | 16.04M | 22.20% | — | 16.04M | — | 8.82M | IN | Wisconsin | 2016-02-16 | ↗ |
| 3 | MPJ Healthcare, LLC | 16.04M | 22.20% | 16.04M | — | 8.82M | — | OO | Wisconsin | 2016-02-16 | ↗ |
| 4 | Whitebox Advisors, LLC | 7.23M | 5.70% | — | 2.86M | — | 2.86M | IA | Cayman Islands | 2020-03-18 | ↗ |
| 5 | Dane Andreeff | 3.34M | 6.30% | 98.5K | 3.24M | 98.5K | 3.24M | IN | — | 2020-11-05 | ↗ |
| 6 | Maple Leaf Capital I, LLC | 3.24M | 6.20% | — | 3.24M | — | 3.24M | OO | — | 2020-11-05 | ↗ |
| 7 | Hudson Bay Capital Management LP | 3.02M | 9.68% | — | 3.02M | — | — | PN | State of Delaware | 2023-02-08 | ↗ |
| 8 | Sander Gerber | 3.02M | 9.68% | — | 3.02M | — | — | IN | State of Delaware | 2023-02-08 | ↗ |
| 9 | BARCLAYS GLOBAL INVESTORS, NA | 2.83M | 2.47% | — | 1.91M | — | 1.91M | BK | Delaware | 2020-03-30 | ↗ |
| 10 | B. Asher | 2.50M | 8.40% | — | 2.50M | — | 2.50M | HC | United States of America | 2022-08-15 | ↗ |
| 11 | Capital LLC | 2.50M | 8.40% | — | 2.50M | — | 2.50M | OO | United States of America | 2022-08-15 | ↗ |
| 12 | P. Kopin | 2.50M | 8.40% | — | 2.50M | — | 2.50M | HC | United States of America | 2022-08-15 | ↗ |
| 13 | Rovida Advisors Inc. | 1.74M | 6.70% | 1.74M | — | 1.74M | — | IA | Delaware | 2019-11-25 | ↗ |
| 14 | Montel Williams | 1.56M | 7.70% | 1.56M | — | 1.56M | — | IN | Delaware | 2018-02-13 | ↗ |
| 15 | Montel Williams Enterprises, Inc. | 1.56M | 7.70% | 1.56M | — | 1.56M | — | CO | Delaware | 2018-02-13 | ↗ |
| 16 | Philippe Deschamps | 1.19M | 3.80% | 1.19M | — | 1.19M | 1.19M | IN | United States | 2020-02-12 | ↗ |
| 17 | BARCLAYS GLOBAL INVESTORS, NA. | 973.9K | 3.41% | — | 3.24M | — | 3.24M | BK | California | 2021-01-20 | ↗ |
| 18 | Jonathan Sackier | 801.4K | 3.90% | 801.4K | — | 801.4K | 801.4K | IN | United States | 2018-02-14 | ↗ |
| 19 | 2. | 324.7K | 8.50% | — | 324.7K | — | 324.7K | PN | California | 2022-02-14 | ↗ |
| 20 | 27-4413262 | 255.4K | 6.80% | 255.4K | — | 255.4K | — | OO | Maryland | 2022-02-11 | ↗ |
| 21 | Identification Nos. of above persons (. | 255.4K | 6.80% | 255.4K | — | 255.4K | — | IN | States | 2022-02-11 | ↗ |
| 22 | Daniel B. Asher | 90.3K | 4.99% | — | 90.3K | — | 78.2K | HC, IN | United States of America | 2024-05-14 | ↗ |
| 23 | Intracoastal Capital LLC | 90.3K | 4.99% | — | 90.3K | — | 78.2K | OO | United States of America | 2024-05-14 | ↗ |
| 24 | Mitchell P. Kopin | 90.3K | 4.99% | — | 90.3K | — | 78.2K | HC, IN | United States of America | 2024-05-14 | ↗ |
| 25 | 94-3262667 | 54.5K | 9.60% | 54.5K | — | 54.5K | — | IA | California, USA | 2023-10-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
6
-41 vs prev Q
New positions
2
Closed positions
39
Increased
3
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | PANTERA CAPITAL PARTNERS LP | 3.89M +— (+0.0%) | 11.23M -46.6M (-80.6%) | 157.64% +0.000 pp | 4.90% -2.466 pp | USD14.89 -80.6% | 2 qtrs — |
| 2 | VR ADVISORY SERVICES LTD | 581.3K +— (+0.0%) | 1.68M -1.9M (-53.2%) | 23.57% +0.000 pp | 0.27% -0.605 pp | USD14.89 -80.6% | 2 qtrs — |
| 3 | VANGUARD GROUP INC | 488.2K +488.2K (+100.0%) | 1.41M +1.4M (+100.0%) | 19.80% +19.798 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 4 | BLACKROCK, INC. | 461.2K +461.2K (+100.0%) | 1.33M +1.3M (+100.0%) | 18.70% +18.702 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 5 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 444.9K +441.2K (+11,764.1%) | 1.29M +1.2M (+2,202.7%) | 18.04% +17.890 pp | 0.00% +0.002 pp | USD2.99 -3.3% | 2 qtrs — |
| 6 | HEL VED CAPITAL MANAGEMENT LTD | 436.0K +— (+0.0%) | 1.26M -3.9M (-75.7%) | 17.68% +0.000 pp | 0.34% -0.755 pp | USD14.89 -80.6% | 2 qtrs — |
| 7 | LPL FINANCIAL LLC | 382.3K +208.6K (+120.1%) | 1.10M -1.5M (-57.3%) | 15.50% +8.457 pp | 0.00% -0.001 pp | USD8.34 -65.3% | 2 qtrs — |
| 8 | GHISALLO CAPITAL MANAGEMENT LLC | 363.3K -363.3K (-50.0%) | 1.05M -4.0M (-79.0%) | 14.73% -14.733 pp | 0.05% -0.117 pp | USD14.89 -80.6% | 2 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 348.0K +348.0K (+100.0%) | 1.01M +1.0M (+100.0%) | 14.11% +14.112 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 10 | AVENIR TECH LTD | 290.7K +290.7K (+100.0%) | 840.0K +840.0K (+100.0%) | 11.79% +11.787 pp | 0.08% +0.077 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 11 | POLAR ASSET MANAGEMENT PARTNERS INC. | 233.4K -1.9M (-89.3%) | 674.4K -14.1M (-95.4%) | 9.46% -78.936 pp | 0.01% -0.157 pp | USD14.89 -80.6% | 2 qtrs — |
| 12 | PARALLAX VOLATILITY ADVISERS, L.P. | 231.6K +231.6K (+100.0%) | 669.3K +669.3K (+100.0%) | 9.39% +9.392 pp | 0.00% +0.001 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 13 | QUATTRO FINANCIAL ADVISORS LLC | 209.0K +209.0K (+100.0%) | 604.0K +604.0K (+100.0%) | 8.48% +8.475 pp | 0.18% +0.180 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 14 | UBS GROUP AG | 181.1K +181.1K (+287,400.0%) | 523.5K +522.5K (+55,705.0%) | 7.34% +7.342 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 2 qtrs — |
| 15 | STATE STREET CORP | 160.7K +160.7K (+100.0%) | 464.4K +464.4K (+100.0%) | 6.52% +6.517 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 16 | CETERA INVESTMENT ADVISERS | 120.1K +120.1K (+100.0%) | 347.0K +347.0K (+100.0%) | 4.87% +4.869 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 17 | JANE STREET GROUP, LLC | 92.0K +92.0K (+100.0%) | 265.9K +265.9K (+100.0%) | 3.73% +3.731 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 18 | CITADEL ADVISORS LLC | 86.4K +86.4K (+100.0%) | 249.7K +249.7K (+100.0%) | 3.50% +3.504 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 19 | MORGAN STANLEY | 86.1K +75.3K (+695.1%) | 248.8K +87.6K (+54.3%) | 3.49% +3.053 pp | 0.00% +0.000 pp | USD4.40 -34.3% | 2 qtrs — |
| 20 | NORTHERN TRUST CORP | 78.3K +78.3K (+100.0%) | 226.3K +226.3K (+100.0%) | 3.18% +3.176 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 21 | CLEAR STREET GROUP INC. | 75.6K +75.6K (+100.0%) | 218.4K +218.4K (+100.0%) | 3.06% +3.064 pp | 0.00% +0.001 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 22 | MARSHALL WACE, LLP | 67.6K +67.6K (+100.0%) | 195.2K +195.2K (+100.0%) | 2.74% +2.740 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 23 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 60.2K +60.2K (+100.0%) | 174.1K +174.1K (+100.0%) | 2.44% +2.443 pp | 0.00% +0.002 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 24 | XTX TOPCO LTD | 48.4K +48.4K (+100.0%) | 139.8K +139.8K (+100.0%) | 1.96% +1.961 pp | 0.00% +0.004 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 25 | ARISTIDES CAPITAL LLC | 47.4K +47.4K (+100.0%) | 137.0K +137.0K (+100.0%) | 1.92% +1.922 pp | 0.02% +0.024 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 26 | OMERS ADMINISTRATION CORP | 30.3K +30.3K (+100.0%) | 87.6K +87.6K (+100.0%) | 1.23% +1.229 pp | 0.00% +0.001 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16.6K +16.6K (+100.0%) | 48.0K +48.0K (+100.0%) | 0.67% +0.673 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 28 | PRICE T ROWE ASSOCIATES INC /MD/ | 15.7K +15.7K (+100.0%) | 46.0K +46.0K (+100.0%) | 0.64% +0.637 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 29 | GRANT PRIVATE WEALTH MANAGEMENT INC | 15.8K +15.8K (+100.0%) | 45.7K +45.7K (+100.0%) | 0.64% +0.641 pp | 0.03% +0.028 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 30 | TWO SIGMA SECURITIES, LLC | 10.3K +10.3K (+100.0%) | 29.6K +29.6K (+100.0%) | 0.42% +0.416 pp | 0.00% +0.004 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 31 | — | 155.6K +155.6K (+100.0%) | 25.0K +25.0K (+100.0%) | 6.31% +6.310 pp | 0.03% +0.031 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 32 | MAI CAPITAL MANAGEMENT | 4.0K +4.0K (+100.0%) | 11.6K +11.6K (+100.0%) | 0.16% +0.162 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 33 | HIGHLINE WEALTH PARTNERS LLC | 500.00 +500.0 (+100.0%) | 1.4K +1.4K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 34 | BANK OF AMERICA CORP /DE/ | 252.00 +243.0 (+2,700.0%) | 728.00 +594.0 (+443.3%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD3.32 -13.0% | 2 qtrs — |
| 35 | AMERICAN CAPITAL ADVISORY, LLC | 235.00 +— (+0.0%) | 680.00 -2.8K (-80.6%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD14.89 -80.6% | 2 qtrs — |
| 36 | JONES FINANCIAL COMPANIES LLLP | 150.00 +150.0 (+100.0%) | 434.00 +434.0 (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD2.89 +0.0% | 1 qtrs NEW |
| 37 | TOWER RESEARCH CAPITAL LLC (TRC) | 20.00 -41.0 (-67.2%) | 58.00 -850.0 (-93.6%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD14.85 -80.5% | 2 qtrs — |
| 38 | DANSKE BANK A/S | 1.00 +— (+0.0%) | 3.00 -12.0 (-80.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.00 -79.4% | 2 qtrs — |
| 39 | IFP ADVISORS, INC | — -66.0 (-100.0%) | — -983.0 (-100.0%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 40 | VIRTU FINANCIAL LLC | — -15.1K (-100.0%) | — -224.0K (-100.0%) | 0.00% -0.611 pp | 0.00% -0.013 pp | USD— | 2 qtrs SOLD |
| 41 | ARISTEIA CAPITAL LLC | — -1.1M (-100.0%) | — -12.2M (-100.0%) | 0.00% -44.199 pp | 0.00% -0.285 pp | USD— | 2 qtrs SOLD |
| 42 | CITIGROUP INC | — -11.0 (-100.0%) | — -164.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 43 | STONEPINE CAPITAL MANAGEMENT, LLC | — -20.0K (-100.0%) | — -297.8K (-100.0%) | 0.00% -0.811 pp | 0.00% -0.242 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.02% | 281.8K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 645.1K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
0
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Mello Sergio | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-04-23 | Lee Michel Kai Tai | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-04-06 | Tjandrasuwita Agustina Gani | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-31 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 23,529 | 6.88 | 161.9K | 23,529 | D | ↗ |
| 2026-03-31 | STRAW EDWARD M | Director | A-Award | A | Class A Common Stock | 2,180 | 0.00 | — | 92,291 | D | ↗ |
| 2026-03-31 | Perkins Sherrie L | Director | A-Award | A | Stock Option (Right to Buy) | 23,529 | 6.88 | 161.9K | 23,529 | D | ↗ |
| 2026-03-31 | BUCKMAN PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 23,529 | 6.88 | 161.9K | 23,529 | D | ↗ |
| 2025-10-30 | Jiang Cosmo Yi | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-18 | Chee Choon Wee | Director / 10% Owner | — | — | COMMON STOCK | 0 | 0.00 | — | 6,830,402 | I | ↗ |
| 2025-07-02 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 2,600 | 9.76 | 25.4K | 2,600 | D | ↗ |
| 2025-07-02 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 2,600 | 9.76 | 25.4K | 2,600 | D | ↗ |
| 2025-07-02 | Perkins Sherrie L | Director | A-Award | A | Stock Option (Right to Buy) | 2,600 | 9.76 | 25.4K | 2,600 | D | ↗ |
| 2025-07-02 | MATHIESEN JEFFREY S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 26,200 | 9.76 | 255.7K | 26,200 | D | ↗ |
| 2025-07-02 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 9.76 | 170.8K | 17,500 | D | ↗ |
| 2025-07-02 | BUCKMAN PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 2,600 | 9.76 | 25.4K | 2,600 | D | ↗ |
| 2025-07-02 | ANDREEFF DANE | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 52,400 | 9.76 | 511.4K | 52,400 | D | ↗ |
| 2025-01-06 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 10,732 | 0.73 | 7.8K | 10,732 | D | ↗ |
| 2025-01-06 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 10,732 | 0.73 | 7.8K | 10,732 | D | ↗ |
| 2025-01-06 | Perkins Sherrie L | Director | A-Award | A | Stock Option (Right to Buy) | 10,732 | 0.73 | 7.8K | 10,732 | D | ↗ |
| 2025-01-06 | MATHIESEN JEFFREY S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 139,857 | 0.73 | 102.0K | 139,857 | D | ↗ |
| 2025-01-06 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 95,892 | 0.73 | 69.9K | 95,892 | D | ↗ |
| 2025-01-06 | BUCKMAN PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 10,732 | 0.73 | 7.8K | 10,732 | D | ↗ |
| 2025-01-06 | ANDREEFF DANE | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 279,715 | 0.73 | 204.0K | 279,715 | D | ↗ |
| 2024-07-02 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 31,000 | 0.97 | 29.9K | 31,000 | — | ↗ |
| 2024-07-02 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 31,000 | 0.97 | 29.9K | 31,000 | — | ↗ |
| 2024-07-02 | Perkins Sherrie L | Director | A-Award | A | Stock Option (Right to Buy) | 31,000 | 0.97 | 29.9K | 31,000 | — | ↗ |
| 2024-07-02 | MATHIESEN JEFFREY S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 404,000 | 0.97 | 389.9K | 404,000 | — | ↗ |
| 2024-07-02 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 277,000 | 0.97 | 267.3K | 277,000 | — | ↗ |
| 2024-07-02 | BUCKMAN PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 31,000 | 0.97 | 29.9K | 31,000 | — | ↗ |
| 2024-07-02 | ANDREEFF DANE | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 808,000 | 0.97 | 779.7K | 808,000 | — | ↗ |
| 2023-12-14 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,827 | 8.10 | 22.9K | 16,512 | — | ↗ |
| 2023-12-01 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 643 | 6.45 | 4.1K | 11,276 | — | ↗ |
| 2023-11-30 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 228 | 6.37 | 1.5K | 2,603 | — | ↗ |
| 2023-08-30 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 141 | 7.64 | 1.1K | 599 | — | ↗ |
| 2023-08-28 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,688 | 6.37 | 17.1K | 8,774 | — | ↗ |
| 2023-05-24 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 284,865 | 0.16 | 44.5K | 284,865 | — | ↗ |
| 2023-05-24 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 284,865 | 0.16 | 44.5K | 284,865 | — | ↗ |
| 2023-05-24 | Perkins Sherrie L | Director | A-Award | A | Class A Common Stock | 83,054 | 0.00 | — | 90,040 | — | ↗ |
| 2023-05-24 | BUCKMAN PAUL | Director | A-Award | A | Class A Common Stock | 83,054 | 0.00 | — | 89,824 | — | ↗ |
| 2023-02-14 | MATHIESEN JEFFREY S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 2,693,000 | 0.31 | 832.1K | 2,693,000 | — | ↗ |
| 2023-02-14 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 1,463,000 | 0.31 | 452.1K | 1,463,000 | — | ↗ |
| 2023-02-14 | ANDREEFF DANE | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 5,181,000 | 0.31 | 1.60M | 5,181,000 | — | ↗ |
| 2022-12-16 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 2,313 | 0.25 | 576.40 | 15,752 | — | ↗ |
| 2022-11-23 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 10,459 | 0.31 | 3.3K | 54,379 | — | ↗ |
| 2022-11-22 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 10,000 | 0.28 | 2.8K | 218,572 | — | ↗ |
| 2022-11-17 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 37,464 | 0.34 | 12.7K | 276,082 | — | ↗ |
| 2022-11-16 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 10,000 | 0.32 | 3.2K | 154,819 | — | ↗ |
| 2022-09-13 | MATHIESEN JEFFREY S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 18,000 | 0.54 | 9.7K | 18,000 | — | ↗ |
| 2022-08-24 | ANDREEFF DANE | Director | P-Purchase | A | Common Stock | 23,937 | 0.63 | 15.1K | 85,780 | — | ↗ |
| 2022-05-23 | Walter Blane | Director | A-Award | A | Class A Common Stock | 6,049 | 0.00 | — | 9,400 | — | ↗ |
| 2022-05-23 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 21,605 | 0.00 | — | 21,605 | — | ↗ |
| 2022-05-23 | Perkins Sherrie L | Director | A-Award | A | Class A Common Stock | 6,049 | 0.00 | — | 6,986 | — | ↗ |
| 2022-05-23 | MATHIESEN JEFFREY S | Officer | A-Award | A | Stock Option (Right to Buy) | 37,000 | 4.68 | 173.2K | 37,000 | — | ↗ |
| 2022-05-23 | BUCKMAN PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 21,605 | 0.00 | — | 21,605 | — | ↗ |
| 2022-05-23 | ANDREEFF DANE | Director | A-Award | A | Stock Option (Right to Buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-02-16 | MATHIESEN JEFFREY S | Officer | A-Award | A | Class A Common Stock | 8,011 | 0.00 | — | 11,948 | — | ↗ |
| 2022-02-16 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 30,000 | 4.68 | 140.4K | 30,000 | — | ↗ |
| 2021-12-17 | MATHIESEN JEFFREY S | Officer | P-Purchase | A | Class A Common Stock | 3,000 | 5.31 | 15.9K | 3,937 | — | ↗ |
| 2021-12-17 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 3,825 | 5.25 | 20.1K | 53,779 | — | ↗ |
| 2021-11-12 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,910 | 8.00 | 23.3K | 17,925 | — | ↗ |
| 2021-09-15 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,408 | 14.72 | 79.6K | 63,522 | — | ↗ |
| 2021-09-10 | BUCKMAN PAUL | Director | A-Award | A | Class A Common Stock | 721 | 0.00 | — | 721 | — | ↗ |
| 2021-09-10 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,155 | 14.96 | 17.3K | 13,860 | — | ↗ |
| 2021-09-08 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,245 | 14.83 | 48.1K | 52,706 | — | ↗ |
| 2021-09-07 | ANDREEFF DANE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 514 | 14.86 | 7.6K | 12,012 | — | ↗ |
| 2021-07-07 | Favit-Van Pelt Antonella R. | Officer | A-Award | A | Stock Option (Right to Buy) | 18,000 | 16.45 | 296.1K | 18,000 | — | ↗ |
| 2021-07-06 | Favit-Van Pelt Antonella R. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-14 | MATHIESEN JEFFREY S | Officer | A-Award | A | Stock Option (Right to Buy) | 77,250 | 15.57 | 1.20M | 77,250 | — | ↗ |
| 2021-06-14 | ANDREEFF DANE | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 195,750 | 15.57 | 3.05M | 195,750 | — | ↗ |
| 2021-06-02 | ANDREEFF DANE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 90,000 | 13.35 | 1.20M | 90,000 | — | ↗ |
| 2021-05-25 | Walter Blane | Director | A-Award | A | Class A Common Stock | 937 | 0.00 | — | 3,351 | — | ↗ |
| 2021-05-25 | Tyler Mitch E | Director | A-Award | A | Stock Option (Right to Buy) | 3,063 | 13.30 | 40.7K | 3,063 | — | ↗ |
| 2021-05-25 | STRAW EDWARD M | Director | A-Award | A | Class A Common Stock | 937 | 0.00 | — | 1,008 | — | ↗ |
| 2021-05-25 | Perkins Sherrie L | Director | A-Award | A | Class A Common Stock | 937 | 0.00 | — | 937 | — | ↗ |
| 2021-05-25 | MATHIESEN JEFFREY S | Director | A-Award | A | Class A Common Stock | 937 | 0.00 | — | 937 | — | ↗ |
| 2021-05-25 | ANDREEFF DANE | Officer | A-Award | A | Class A Common Stock | 937 | 0.00 | — | 1,508 | — | ↗ |
| 2021-04-01 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 2,668 | 0.00 | — | 12,244 | — | ↗ |
| 2021-03-15 | Perkins Sherrie L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-01 | ANDREEFF DANE | Director / Officer | A-Award | A | Warrant (Right to Buy) | 3,234 | 16.30 | 52.7K | 3,234 | — | ↗ |
| 2020-10-21 | LaViscount Joyce N | Officer | A-Award | A | Warrant (Right to Buy) | 19,069 | 0.46 | 8.8K | 19,069 | — | ↗ |
| 2020-10-21 | ANDREEFF DANE | Officer | A-Award | A | Warrant (Right to Buy) | 18,681 | 0.46 | 8.6K | 18,681 | — | ↗ |
| 2020-10-05 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 60,000 | 0.40 | 23.7K | 60,000 | — | ↗ |
| 2020-10-05 | LaViscount Joyce N | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 0.40 | 39.5K | 100,000 | — | ↗ |
| 2020-07-31 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 4,946 | 0.56 | 2.7K | 110,605 | — | ↗ |
| 2020-07-15 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 5,312 | 0.52 | 2.7K | 105,659 | — | ↗ |
| 2020-06-30 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 6,429 | 0.43 | 2.8K | 100,347 | — | ↗ |
| 2020-06-15 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 5,602 | 0.49 | 2.7K | 93,918 | — | ↗ |
| 2020-06-10 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 36,697 | 0.55 | 20.0K | 89,862 | — | ↗ |
| 2020-06-10 | Tyler Mitch E | Director | A-Award | A | Stock Option (Right to Buy) | 36,697 | 0.55 | 20.0K | 135,903 | — | ↗ |
| 2020-06-10 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 36,697 | 0.55 | 20.0K | 96,900 | — | ↗ |
| 2020-06-10 | MATHIESEN JEFFREY S | Director | — | D | Stock Option (Right to Buy) | 36,697 | 0.55 | 20.0K | 0 | — | ↗ |
| 2020-06-10 | ANDREEFF DANE | Director | A-Award | A | Stock Option (Right to Buy) | 36,697 | 0.55 | 20.0K | 59,681 | — | ↗ |
| 2020-05-29 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 5,557 | 0.49 | 2.7K | 88,316 | — | ↗ |
| 2020-05-15 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 5,501 | 0.50 | 2.8K | 82,759 | — | ↗ |
| 2020-05-15 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 31,620 | 0.56 | 17.7K | 443,959 | — | ↗ |
| 2020-05-14 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 26,985 | 0.56 | 15.1K | 728,374 | — | ↗ |
| 2020-05-13 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 80,954 | 0.57 | 46.1K | 701,389 | — | ↗ |
| 2020-04-30 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 6,399 | 0.43 | 2.8K | 77,258 | — | ↗ |
| 2020-04-30 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 9,320 | 0.43 | 4.0K | 90,858 | — | ↗ |
| 2020-04-16 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 0.32 | 16.0K | 50,000 | — | ↗ |
| 2020-04-15 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 10,167 | 0.27 | 2.7K | 70,859 | — | ↗ |
| 2020-04-15 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 14,809 | 0.27 | 4.0K | 81,538 | — | ↗ |
| 2020-03-31 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 8,319 | 0.33 | 2.7K | 60,692 | — | ↗ |
| 2020-03-31 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 12,117 | 0.33 | 4.0K | 66,729 | — | ↗ |
| 2020-03-19 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 0.30 | 15.0K | 50,000 | — | ↗ |
| 2020-03-13 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 5,841 | 0.47 | 2.7K | 52,373 | — | ↗ |
| 2020-03-13 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 8,507 | 0.47 | 4.0K | 54,612 | — | ↗ |
| 2020-02-28 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 3,016 | 0.91 | 2.7K | 46,532 | — | ↗ |
| 2020-02-28 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 4,394 | 0.91 | 4.0K | 46,105 | — | ↗ |
| 2020-02-14 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 3,229 | 0.85 | 2.7K | 43,516 | — | ↗ |
| 2020-02-14 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 4,704 | 0.85 | 4.0K | 41,711 | — | ↗ |
| 2020-01-31 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 2,718 | 1.01 | 2.7K | 40,287 | — | ↗ |
| 2020-01-31 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 3,959 | 1.01 | 4.0K | 37,007 | — | ↗ |
| 2020-01-15 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 2,639 | 1.04 | 2.7K | 37,569 | — | ↗ |
| 2020-01-15 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 3,844 | 1.04 | 4.0K | 33,048 | — | ↗ |
| 2019-12-31 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 2,830 | 0.97 | 2.7K | 34,930 | — | ↗ |
| 2019-12-31 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 4,122 | 0.97 | 4.0K | 29,204 | — | ↗ |
| 2019-12-13 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock | 6,239 | 0.44 | 2.7K | 32,100 | — | ↗ |
| 2019-12-13 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock | 9,087 | 0.44 | 4.0K | 25,082 | — | ↗ |
| 2019-12-07 | Walter Blane | Director | D-Return | D | Stock Option (Right to Buy) | 10,000 | 4.48 | 44.8K | 0 | — | ↗ |
| 2019-12-07 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 120,000 | 5.35 | 642.0K | 120,000 | — | ↗ |
| 2019-12-07 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 5.35 | 107.0K | 20,000 | — | ↗ |
| 2019-12-07 | Peng Huaizheng | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 5.35 | 80.3K | 15,000 | — | ↗ |
| 2019-12-07 | LaViscount Joyce N | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 20,000 | 12.52 | 250.4K | 20,000 | — | ↗ |
| 2019-12-07 | GRIFFIN THOMAS E | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 4.98 | 99.6K | 20,000 | — | ↗ |
| 2019-12-07 | Deschamps Philippe | Director / Officer | D-Return | D | Employee Stock Option (Right to Buy) | 300,000 | 5.35 | 1.61M | 0 | — | ↗ |
| 2019-11-27 | ANDREEFF DANE | Director | A-Award | A | Class A Common Stock | 65,721 | 0.35 | 23.0K | 132,004 | — | ↗ |
| 2019-10-29 | LaViscount Joyce N | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 1.73 | 259.5K | 150,000 | — | ↗ |
| 2019-04-05 | Deschamps Philippe | Director / Officer | M-Exempt | A | Class A Common Stock | 5,018 | 5.60 | 28.1K | 15,995 | — | ↗ |
| 2019-03-28 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 18,990 | 6.76 | 128.4K | 18,990 | — | ↗ |
| 2019-03-28 | Tyler Mitch E | Director | A-Award | A | Stock Option (Right to Buy) | 14,733 | 6.76 | 99.6K | 14,733 | — | ↗ |
| 2019-03-28 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 6.76 | 676.0K | 100,000 | — | ↗ |
| 2019-03-28 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 16,218 | 6.76 | 109.6K | 16,218 | — | ↗ |
| 2019-03-28 | Peng Huaizheng | Director | A-Award | A | Stock Option (Right to Buy) | 15,525 | 6.76 | 104.9K | 15,525 | — | ↗ |
| 2019-03-28 | LaViscount Joyce N | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 6.76 | 676.0K | 100,000 | — | ↗ |
| 2019-03-28 | GRIFFIN THOMAS E | Director | A-Award | A | Stock Option (Right to Buy) | 18,891 | 6.76 | 127.7K | 18,891 | — | ↗ |
| 2019-03-28 | Deschamps Philippe | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 160,000 | 6.76 | 1.08M | 160,000 | — | ↗ |
| 2019-03-28 | ANDREEFF DANE | Director | A-Award | A | Stock Option (Right to Buy) | 17,901 | 6.76 | 121.0K | 17,901 | — | ↗ |
| 2018-07-09 | Laux Jennifer | Officer | A-Award | A | Employee Stock Option (right to buy) | 150,000 | 9.69 | 1.45M | 150,000 | — | ↗ |
| 2018-06-27 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 304 | 10.11 | 3.1K | 326,555 | — | ↗ |
| 2018-06-26 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 1,379 | 10.10 | 13.9K | 1,489,932 | — | ↗ |
| 2018-06-25 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 2,757 | 10.10 | 27.8K | 1,488,553 | — | ↗ |
| 2018-05-15 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 10.99 | 164.9K | 15,000 | — | ↗ |
| 2018-05-15 | Tyler Mitch E | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.99 | 137.4K | 12,500 | — | ↗ |
| 2018-05-15 | Sackier Jonathan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 80,000 | 10.99 | 879.2K | 80,000 | — | ↗ |
| 2018-05-15 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.99 | 137.4K | 12,500 | — | ↗ |
| 2018-05-15 | Peng Huaizheng | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.99 | 137.4K | 12,500 | — | ↗ |
| 2018-05-15 | LaViscount Joyce N | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 80,000 | 10.99 | 879.2K | 80,000 | — | ↗ |
| 2018-05-15 | GRIFFIN THOMAS E | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 10.99 | 164.9K | 15,000 | — | ↗ |
| 2018-05-15 | Deschamps Philippe | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 95,000 | 10.99 | 1.04M | 95,000 | — | ↗ |
| 2018-05-15 | ANDREEFF DANE | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 10.99 | 164.9K | 15,000 | — | ↗ |
| 2018-04-13 | GRIFFIN THOMAS E | Director | P-Purchase | A | Class A Common Stock | 3,346 | 7.47 | 25.0K | 3,346 | — | ↗ |
| 2018-03-15 | Sackier Jonathan | Officer | J-Other | A | Class A Common Stock | 62,002 | 0.00 | — | 703,403 | — | ↗ |
| 2018-01-10 | Tyler Mitch E | Director | J-Other | A | Class A Common Stock | 829,545 | 0.00 | — | 829,545 | — | ↗ |
| 2017-12-22 | Walter Blane | Director | P-Purchase | A | Warrant (Right to Buy) | 382,653 | 2.45 | 937.5K | 382,653 | — | ↗ |
| 2017-12-22 | LaViscount Joyce N | Officer | P-Purchase | A | Warrant (Right to Buy) | 79,082 | 2.45 | 193.8K | 79,082 | — | ↗ |
| 2017-12-22 | Deschamps Philippe | Director / Officer | P-Purchase | A | Class A Common Stock | 127,551 | 1.96 | 250.0K | 3,334,556 | — | ↗ |
| 2017-12-22 | ANDREEFF DANE | Director | P-Purchase | A | Warrant (Right to Buy) | 83,147 | 2.45 | 203.7K | 83,147 | — | ↗ |
| 2017-11-17 | Walter Blane | Director | P-Purchase | A | Class A Common Stock | 20,000 | 2.51 | 50.3K | 40,000 | — | ↗ |
| 2017-11-16 | Walter Blane | Director | P-Purchase | A | Class A Common Stock | 20,000 | 2.40 | 48.1K | 20,000 | — | ↗ |
| 2017-11-13 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 3,039 | 2.23 | 6.8K | 294,411 | — | ↗ |
| 2017-11-10 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 45,233 | 2.59 | 117.2K | 1,330,979 | — | ↗ |
| 2017-11-09 | ANDREEFF DANE | Director | P-Purchase | A | Class A Common Stock | 7,293 | 2.70 | 19.7K | 281,405 | — | ↗ |
| 2017-08-08 | ANDREEFF DANE | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 2.08 | 208.0K | 100,000 | — | ↗ |
| 2017-08-04 | ANDREEFF DANE | Director | — | I | Class A Common Stock | 0 | 0.00 | — | 1,252,649 | — | ↗ |
| 2017-04-17 | Walter Blane | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.63 | 163.0K | 100,000 | — | ↗ |
| 2017-04-17 | Tyler Mitch E | Director | A-Award | A | Stock Option (Right to Buy) | 85,000 | 1.63 | 138.6K | 85,000 | — | ↗ |
| 2017-04-17 | Sackier Jonathan | Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 326,624 | 1.63 | 532.4K | 326,624 | — | ↗ |
| 2017-04-17 | STRAW EDWARD M | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.63 | 163.0K | 100,000 | — | ↗ |
| 2017-04-17 | Peng Huaizheng | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.63 | 163.0K | 100,000 | — | ↗ |
| 2017-04-17 | LaViscount Joyce N | Officer | A-Award | A | Stock Option (Right to Buy) | 800,000 | 1.63 | 1.30M | 800,000 | — | ↗ |
| 2017-04-17 | GRIFFIN THOMAS E | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.63 | 163.0K | 100,000 | — | ↗ |
| 2017-04-17 | Deschamps Philippe | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 1,000,000 | 1.63 | 1.63M | 1,000,000 | — | ↗ |
| 2016-08-08 | GRIFFIN THOMAS E | Director | — | D | Stock Option (Right to Buy) | 100,000 | 1.00 | 100.0K | 0 | — | ↗ |
| 2016-07-13 | Walter Blane | Director | A-Award | A | Stock Option | 100,000 | 1.07 | 107.0K | 100,000 | — | ↗ |
| 2016-07-13 | Sackier Jonathan | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 600,000 | 1.07 | 642.0K | 600,000 | — | ↗ |
| 2016-07-13 | STRAW EDWARD M | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.07 | 107.0K | 100,000 | — | ↗ |
| 2016-07-13 | Peng Huaizheng | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.07 | 80.3K | 75,000 | — | ↗ |
| 2016-07-13 | LaViscount Joyce N | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 600,000 | 1.07 | 642.0K | 600,000 | — | ↗ |
| 2016-07-13 | Deschamps Philippe | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,500,000 | 1.07 | 1.61M | 1,500,000 | — | ↗ |
| 2016-07-13 | Bapty Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.07 | 53.5K | 50,000 | — | ↗ |
| 2016-04-18 | LaViscount Joyce N | Officer | A-Award | A | Class A Common Stock, Without Par Value | 50,224 | 0.77 | 38.7K | 50,224 | — | ↗ |
| 2016-04-18 | Deschamps Philippe | Director / Officer | A-Award | A | Class A Common Stock, Without Par Value | 50,186 | 0.77 | 38.6K | 54,886 | — | ↗ |
| 2016-04-18 | Bapty Brian | Officer | A-Award | A | Class A Common Stock, Without Par Value | 50,000 | 0.77 | 38.5K | 332,700 | — | ↗ |
| 2016-04-05 | Deschamps Philippe | Director / Officer | A-Award | A | Warrant | 25,093 | 0.00 | — | 25,093 | — | ↗ |
| 2016-01-07 | A&B (HK) Co Ltd | 10% Owner | — | D | Warrant | 2,777,778 | 1.35 | 3.75M | 0 | — | ↗ |
| 2015-12-29 | Walter Blane | Director | — | D | Stock Option (Right to Buy) | 50,000 | 0.90 | 45.0K | 0 | — | ↗ |
| 2015-12-29 | Peng Huaizheng | Director | — | D | Stock Option (Right to Buy) | 50,000 | 0.90 | 45.0K | 0 | — | ↗ |
| 2015-12-29 | A&B (HK) Co Ltd | 10% Owner | — | D | Class A Common Stock | 0 | 0.00 | — | 7,638,889 | — | ↗ |
| 2015-11-10 | A&B (HK) Co Ltd | 10% Owner | — | D | Warrant | 1,041,667 | 1.44 | 1.50M | 0 | — | ↗ |
| 2015-11-02 | Bapty Brian | Officer | — | D | Class A Common Stock, Without Par Value | 0 | 0.00 | — | 282,700 | — | ↗ |
| 2015-10-21 | LaViscount Joyce N | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 750,000 | 0.67 | 502.5K | 750,000 | — | ↗ |
| 2015-09-10 | STRAW EDWARD M | Director | P-Purchase | A | Class A Common Stock | 12,500 | 0.80 | 10.0K | 12,500 | — | ↗ |
| 2015-05-14 | Tyler Mitch E | Director | — | D | Stock Option (Right to Buy) | 400,000 | 0.50 | 200.0K | 0 | — | ↗ |
| 2015-05-14 | Tseng Amanda | Officer | — | D | Stock Option (Right to Buy) | 60,000 | 0.50 | 30.0K | 0 | — | ↗ |
| 2015-05-14 | Sackier Jonathan | Officer | — | D | Stock Option (Right to Buy) | 400,000 | 2.46 | 984.0K | 0 | — | ↗ |
| 2015-05-14 | STRAW EDWARD M | Director | — | D | Stock Option (Right to Buy) | 100,000 | 2.42 | 242.0K | 0 | — | ↗ |
| 2015-05-14 | MPJ Healthcare, LLC | 10% Owner | — | D | Class A Common Stock, Without Par Value | 0 | 0.00 | — | 16,035,026 | — | ↗ |
| 2015-05-14 | LaViscount Joyce N | Director | — | D | Stock Option (Right to Buy) | 100,000 | 2.66 | 266.0K | 0 | — | ↗ |
| 2015-05-14 | Kaczmarek Kurt | 10% Owner | — | D | Stock Option (Right to Buy) | 400,000 | 0.50 | 200.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-19.2K
Shares Outstanding
40.30M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph Chee Executive Chairman | 91.3K | 213.8K | 6.63M | — | — | 578.00 | 6.94M | 95.59% | ↗ |
| 2 | 2025 | Dane C. Andreeff President and Chief Executive Officer | 419.0K | 890.0K | — | 636.5K | 146.7K | 33.5K | 2.13M | 29.94% | ↗ |
| 3 | 2025 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 401.0K | 610.0K | — | 318.0K | 112.3K | 38.1K | 1.48M | 21.50% | ↗ |
| 4 | 2024 | Dane C. Andreeff President and Chief Executive Officer | 402.0K | — | — | 682.8K | 146.7K | 37.9K | 1.27M | 53.79% | ↗ |
| 5 | 2024 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 385.0K | — | — | 341.4K | 112.4K | 35.2K | 874.0K | 39.06% | ↗ |
| 6 | 2024 | Antonella Favit-Van Pelt Chief Medical Officer | 390.0K | — | — | 234.1K | 99.6K | 31.7K | 755.5K | 30.98% | ↗ |
| 7 | 2023 | Dane C. Andreeff President and Chief Executive Officer | 386.0K | — | — | 1.12M | 96.5K | 37.3K | 1.64M | 68.21% | ↗ |
| 8 | 2023 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 370.0K | — | — | 579.8K | 74.0K | 34.6K | 1.06M | 54.78% | ↗ |
| 9 | 2023 | Antonella Favit-Van Pelt Chief Medical Officer | 375.0K | — | — | 315.0K | 65.6K | 30.9K | 786.5K | 40.05% | ↗ |
| 10 | 2022 | Dane C. Andreeff President and Chief Executive Officer | 367.5K | — | — | 133.6K | 91.9K | 9.8K | 602.7K | 22.16% | ↗ |
| 11 | 2022 | Antonella Favit-Van Pelt Chief Medical Officer | 357.0K | — | — | 93.9K | 62.5K | 13.2K | 526.2K | 17.84% | ↗ |
| 12 | 2022 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 351.8K | — | — | 28.2K | 70.4K | 12.8K | 463.5K | 6.08% | ↗ |
| 13 | 2021 | Dane C. Andreeff President and Chief Executive Officer | 192.2K | — | 15.0K | 3.84M | 90.1K | 7.1K | 4.15M | 93.02% | ↗ |
| 14 | 2021 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 184.0K | — | 18.0K | 1.14M | 69.0K | 11.4K | 1.42M | 81.41% | ↗ |
| 15 | 2021 | Joyce LaViscount Former Chief Financial Officer, Chief Operating Officer and Secretary | 206.3K | — | 38.7K | 40.6K | — | 442.2K | 727.7K | 10.90% | ↗ |
| 16 | 2021 | Antonella Favit-Van Pelt Chief Medical Officer | 164.8K | — | — | 193.1K | 56.5K | — | 414.4K | 46.58% | ↗ |
| 17 | 2020 | Philippe Deschamps Former Chief Executive Officer | 285.3K | — | — | — | — | 501.6K | 786.9K | 0.00% | ↗ |
| 18 | 2020 | Joyce LaViscount Chief Financial Officer, Chief Operating Officer and Secretary | 387.1K | — | 17.6K | 24.3K | 77.4K | 1.2K | 507.6K | 8.26% | ↗ |
| 19 | 2020 | Joyce LaViscount Former Chief Financial Officer, Chief Operating Officer and Secretary | 387.1K | — | 17.6K | 24.3K | 77.4K | 1.2K | 507.6K | 8.26% | ↗ |
| 20 | 2020 | Jonathan Sackier Former Chief Medical Officer | 200.0K | — | — | 25.7K | 40.0K | 1.7K | 267.4K | 9.63% | ↗ |
| 21 | 2020 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 5.0K | — | — | 20.0K | — | — | 25.0K | 80.00% | ↗ |
| 22 | 2020 | Dane C. Andreeff Interim President and Chief Executive Officer | — | — | — | 20.0K | — | 2.5K | 22.5K | 88.89% | ↗ |
| 23 | 2020 | Dane C. Andreeff President and Chief Executive Officer | — | — | — | 20.0K | — | 2.5K | 22.5K | 88.89% | ↗ |
| 24 | 2019 | Philippe Deschamps Former Chief Executive Officer | 492.4K | — | — | 739.8K | — | 12.4K | 1.24M | 59.44% | ↗ |
| 25 | 2019 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 376.5K | — | — | 642.7K | 138.4K | 8.4K | 1.17M | 54.86% | ↗ |
| 26 | 2019 | Joyce LaViscount Chief Financial Officer, Chief Operating Officer and Secretary | 382.0K | — | — | 642.7K | — | 8.4K | 1.03M | 62.22% | ↗ |
| 27 | 2019 | Jonathan Sackier Chief Medical Officer | 336.6K | — | — | 462.4K | 153.5K | — | 958.0K | 48.26% | ↗ |
| 28 | 2019 | Jonathan Sackier Former Chief Medical Officer | 336.6K | — | — | 462.4K | — | — | 798.9K | 57.87% | ↗ |
| 29 | 2019 | Philippe Deschamps Chief Executive Officer | 484.4K | — | — | 739.8K | 235.7K | 12.4K | 480.2K | 154.07% | ↗ |
| 30 | 2019 | Dane C. Andreeff Interim President and Chief Executive Officer | — | — | — | 79.1K | — | — | 79.1K | 100.00% | ↗ |
| 31 | 2018 | Philippe Deschamps Chief Executive Officer | 424.3K | — | — | 721.3K | 99.8K | 13.5K | 1.26M | 57.30% | ↗ |
| 32 | 2018 | Jennifer Laux Chief Commercialization Officer | 153.3K | — | — | 1.02M | 48.0K | 5.3K | 1.23M | 83.21% | ↗ |
| 33 | 2018 | Jonathan Sackier Chief Medical Officer | 318.2K | — | — | 607.4K | 62.4K | — | 988.1K | 61.48% | ↗ |
| 34 | 2018 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 342.7K | — | — | 607.4K | 67.2K | 8.2K | 25.6K | 2,374.70% | ↗ |
| 35 | 2017 | Philippe Deschamps Chief Executive Officer | 411.3K | — | — | 1.17M | 99.8K | 18.0K | 1.70M | 68.82% | ↗ |
| 36 | 2017 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 325.5K | — | — | 934.4K | 67.2K | 12.0K | 1.34M | 69.78% | ↗ |
| 37 | 2017 | Philippe Deschamps Chief Executive Officer Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 300.0K | — | — | 205.8K | 56.3K | 12.0K | 667.7K | 30.83% | ↗ |
| 38 | 2016 | Philippe Chief Executive Officer | 400.0K | 120.0K | — | — | — | 15.0K | 535.0K | 0.00% | ↗ |
| 39 | 2016 | Deschamps Joyce Chief Financial Officer and Chief Operating | 137.5K | — | — | 205.8K | — | 5.5K | 348.8K | 59.01% | ↗ |
| 40 | 2016 | LaViscount Jonathan Chief Medical Officer | 300.0K | — | — | — | — | — | 300.0K | 0.00% | ↗ |
| 41 | 2016 | Phillipe Deschamps Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 42 | 2015 | Philippe Chief Executive Officer | 360.4K | — | — | 432.2K | — | 5.0K | 797.6K | 54.19% | ↗ |
| 43 | 2015 | LaViscount Jonathan Chief Medical Officer | 100.0K | — | — | 449.8K | — | — | 549.8K | 81.81% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dane Carl Andreeff | President, Chief Executive Officer & Director | 1M | male |
| Jeffrey S. Mathiesen | Chief Financial Officer, Treasurer & Secretary | 1M | male |
| Antonella Favit-Van Pelt | Chief Medical Officer | 521.4K | — |
| Choon Wee Chee | Executive Chairman | 305.7K | male |
| Agustina Gani Tjandrasuwita | COO & Deputy CFO | — | female |
| Lawrence Picciano | Senior Vice President of Engineering, Quality & Regulatory Affairs | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HSDT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
